EBI2介导的桥接通道定位支持脾树突状细胞稳态和颗粒性抗原捕获。
EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture.
作者信息
Yi Tangsheng, Cyster Jason G
机构信息
Department of Microbiology and Immunology , University of California, San Francisco , San Francisco , United States ; Howard Hughes Medical Institute, University of California, San Francisco , San Francisco , United States.
出版信息
Elife. 2013 May 14;2:e00757. doi: 10.7554/eLife.00757.
Splenic dendritic cells (DCs) present blood-borne antigens to lymphocytes to promote T cell and antibody responses. The cues involved in positioning DCs in areas of antigen exposure in the spleen are undefined. Here we show that CD4(+) DCs highly express EBI2 and migrate to its oxysterol ligand, 7α,25-OHC. In mice lacking EBI2 or the enzymes needed for generating normal distributions of 7α,25-OHC, CD4(+) DCs are reduced in frequency and the remaining cells fail to situate in marginal zone bridging channels. The CD4(+) DC deficiency can be rescued by LTβR agonism. EBI2-mediated positioning in bridging channels promotes DC encounter with blood-borne particulate antigen. Upon exposure to antigen, CD4(+) DCs move rapidly to the T-B zone interface and promote induction of helper T cell and antibody responses. These findings establish an essential role for EBI2 in CD4(+) DC positioning and homeostasis and in facilitating capture and presentation of blood-borne particulate antigens. DOI:http://dx.doi.org/10.7554/eLife.00757.001.
脾脏树突状细胞(DCs)将血源性抗原呈递给淋巴细胞,以促进T细胞和抗体反应。目前尚不清楚脾脏中引导DCs定位到抗原暴露区域的线索。在此我们发现,CD4(+) DCs高表达EBI2,并迁移至其氧化甾醇配体7α,25-OHC处。在缺乏EBI2或生成正常分布的7α,25-OHC所需酶的小鼠中,CD4(+) DCs的频率降低,剩余细胞无法定位在边缘区桥接通道中。LTβR激动剂可挽救CD4(+) DCs的缺陷。EBI2介导的在桥接通道中的定位促进DCs与血源性颗粒抗原相遇。暴露于抗原后,CD4(+) DCs迅速迁移至T-B区界面,促进辅助性T细胞的诱导和抗体反应。这些发现确立了EBI2在CD4(+) DCs定位和稳态以及促进血源性颗粒抗原捕获和呈递中的重要作用。DOI:http://dx.doi.org/10.7554/eLife.00757.001
相似文献
Nature. 2011-7-27
Nature. 2011-7-27
引用本文的文献
Front Immunol. 2025-2-28
Nat Rev Immunol. 2025-2
Proc Natl Acad Sci U S A. 2023-8-15
Curr Opin Immunol. 2023-8
Immunol Rev. 2023-8
本文引用的文献
Nat Immunol. 2012-11-16
Nat Immunol. 2012-7-15
Proc Natl Acad Sci U S A. 2012-6-26
Immunity. 2011-11-23